Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Peter, Van Hoogevest"'
Autor:
Praneeth R. Kuninty, Karin Binnemars-Postma, Ahmed Jarray, Kunal P. Pednekar, Marcel A. Heinrich, Helen J. Pijffers, Hetty ten Hoopen, Gert Storm, Peter van Hoogevest, Wouter K. den Otter, Jai Prakash
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Tumor-associated macrophages are mostly pro-tumorigenic, due to their re-programming by the tumor microenvironment. Here authors show that nanoliposomes, incorporating phospholipids with a flipping-tail chain, are engulfed specifically by intratumora
Externí odkaz:
https://doaj.org/article/c7139cc6942449fc878247554c64ac93
Autor:
Simon Drescher, Peter van Hoogevest
Publikováno v:
Pharmaceutics, Vol 12, Iss 12, p 1235 (2020)
This review summarizes the research on phospholipids and their use for drug delivery related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that have been approved by the PRC since 2017 and are currently still ongoing
Externí odkaz:
https://doaj.org/article/9c4018d072ff427ab7d00f269bae3c68
Autor:
Simone Aleandri, Lisa Rahnfeld, Despo Chatzikleanthous, Alessandra Bergadano, Claudia Bühr, Carlotta Detotto, Sara Fuochi, Kevin Weber-Wilk, Stefan Schürch, Peter van Hoogevest, Paola Luciani
Publikováno v:
Aleandri, Simone; Rahnfeld, Lisa; Chatzikleanthous, Despo; Bergadano, Alessandra; Bühr, Claudia; Detotto, Carlotta; Fuochi, Sara; Weber-Wilk, Kevin; Schürch, Stefan; van Hoogevest, Peter; Luciani, Paola (2022). Development and in vivo validation of phospholipid-based depots for the sustained release of bupivacaine. European journal of pharmaceutics and biopharmaceutics, 181, pp. 300-309. Elsevier 10.1016/j.ejpb.2022.11.019
By direct deposition of the drug at the local site of action, injectable depot formulations - intended for treatment of a local disease or for local intervention - are designed to limit the immediate exposure of the active principle at a systemic lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97837022c8d8a5c8e8addfcc57f0b967
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 168:10-17
Compared to conventional parenteral formulations injectable depot formulations, owing to a sustained drug release, offer several advantages, such as a reduced dosing frequency - and consequent improved compliance - or a predictable release profile. A
Autor:
Georgios Imanidis, Marc Sutter, Susanne Reitbauer, Susanne B. Kapitza, Peter van Hoogevest, Daniel Hummel, Beat Müller, Peter Lütolf
Publikováno v:
CHIMIA, Vol 60, Iss 1-2 (2006)
A series of theoretical models is presented to describe the processes of drug release and absorption following non-invasive administration by the intestinal and the (trans)dermal route. These models are used to analyze experimental data and provide t
Externí odkaz:
https://doaj.org/article/87a5b02747f04092841aa41f1f681d31
Publikováno v:
European Journal of Pharmaceutical Sciences. 108:93-100
Phospholipid-based formulations provide a key technology to formulate poorly water-soluble drugs. A recent interest has been in using phospholipids with a high content of monoacyl phosphatidylcholine (monoacyl PC) due to its ability to form mixed mic
Publikováno v:
AAPS PharmSciTech. 20
The aims of this study were to prepare hydrogenated soybean phosphatidylcholine (HSPC) matrices by hot melt extrusion and to evaluate resulting matrix potential to extend drug release in regard to drug loading and solubility for oral drug delivery of
Autor:
Peter van Hoogevest, Alfred Fahr
Publikováno v:
Nanocosmetics ISBN: 9783030165727
Phospholipids are attractive components in cosmetic products because of their natural origin and multifunctional properties. They are used, technically as surface-active compounds, but also as cosmetic actives and modulator of skin penetration. Three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::046ba2f0c9660dc9e785b1b3f4a5cce4
https://doi.org/10.1007/978-3-030-16573-4_6
https://doi.org/10.1007/978-3-030-16573-4_6
Publikováno v:
European Journal of Lipid Science and Technology. 123:2000297